Experiences with

Lenvatinib

. ----- Does anybody have any experience with or opinions on this trial: PLANE/PC - Phase 2 - Pembrolizumab + Lenvatinib https://clinicaltrials.gov/study/NCT04848337

At the end of February the medical staff had secured funding to treat me with a fairly recent drug , Lenvatinib also known as Lenvima . I have been on this treatment since early March and so far have had no dramatic side effects.

Hi everybody, this is Marcellus from the Netherlands….I was wondering: I am going to participate in the Keynote 365 Trial, cohort F/G Pembrolizumab (Keytruda) combined with Lenvatinib. Are there others who participate or have participated in this specific trial? What is/has been your experience?

My dad may be starting a trial combining keytruda and lenvatinib. He hasn’t undergone any genomic testing and I’m not sure he will respond on the basis that while it can be effective for a small subgroup I wonder if there is a more appropriate trial he should be considering?

Have you been diagnosed with HCC and are currently on oral systemic therapy drug treatment for liver cancer (for example, sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, or cabozantinib)? If so, we’d like to ask for your help.

Urgent help needed We are looking for one or two patients who have liver cancer and are currently being treated by systemic drug therapy (e.g. regorafenib, nivolu¬mab, lenvatinib, pembrolizumab, and cabozantinib) to help us with the design of a patient survey.

Good evening one and all, just would like to find out if anyone has had experience with Lenvatinib? hope someone can help me understand the effects of this drug.... with thanks.

They have started steroids and are recommending Lenvatinib (chemotherapy) and / or Nivolumab (immunotherapy).

From: https://meetinglibrary.asco.org/record/175766/abstract Phase 1 study of Lenvatinib and Letrozole: Lenvatinib, an approved drug that is used to treat liver, thyroid, and kidney cancer, is currently being studied against other types of cancer.

I'm personally looking for one HCC patient* who is taking Lenvima (aka lenvatinib). I would like to interview you for a special project. We would conduct the interview online. Compensation TBD. Please email me directly and put 'Lenvima patient' in the subject line. Thank you!

Lenvima® (lenvatinib) launched in the UK on June 9, a treatment option for people with radioactive iodine refractory differentiated thyroid cancer (RAI refractory DTC).1 Advanced thyroid cancer is a difficult to treat condition with a poor prognosis and lenvatinib represents a significant step forward